Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Fuyuan Biotechnology is a prominent Chinese industrial biotechnology firm focused on the production of gluconate-based chemicals through advanced fermentation processes. Established in 2004 and headquartered in Tengzhou, the company is a leading global manufacturer of sodium gluconate, glucono-delta-lactone (GDL), and gluconic acid. These products are widely utilized across the food, pharmaceutical, and construction sectors, serving as acidifiers, chelating agents, and pharmaceutical intermediates. The company maintains large-scale manufacturing facilities that adhere to international quality standards, including ISO and GMP certifications for food and pharmaceutical additives. Shandong Fuyuan Biotechnology exports its products to numerous international markets, supporting diverse industrial applications from food preservation to concrete admixtures.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Fuyuan Bio-Tech.